{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:52:32Z","timestamp":1790315552818,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1151153"],"award-info":[{"award-number":["OPP1151153"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Several prolonged typhoid fever epidemics have been reported since 2010 throughout eastern and southern Africa, including Malawi, caused by multidrug-resistant <jats:italic>Salmonella<\/jats:italic> Typhi. The World Health Organization recommends the use of typhoid conjugate vaccines (TCVs) in outbreak settings; however, current data are limited on how and when TCVs might be introduced in response to outbreaks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodology<\/jats:title>\n                <jats:p>We developed a stochastic model of typhoid transmission fitted to data from Queen Elizabeth Central Hospital in Blantyre, Malawi from January 1996 to February 2015. We used the model to evaluate the cost-effectiveness of vaccination strategies over a 10-year time horizon in three scenarios: (1) when an outbreak is likely to occur; (2) when an outbreak is unlikely to occur within the next ten years; and (3) when an outbreak has already occurred and is unlikely to occur again. We considered three vaccination strategies compared to the status quo of no vaccination: (a) preventative routine vaccination at 9\u00a0months of age; (b) preventative routine vaccination plus a catch-up campaign to 15\u00a0years of age; and (c) reactive vaccination with a catch-up campaign to age 15 (for Scenario 1). We also explored variations in outbreak definitions, delays in implementation of reactive vaccination, and the timing of preventive vaccination relative to the outbreak.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Assuming an outbreak occurs within 10\u00a0years, we estimated that the various vaccination strategies would prevent a median of 15\u201360% of disability-adjusted life-years (DALYs). Reactive vaccination was the preferred strategy for WTP values of $0\u2013300 per DALY averted. For WTP values\u2009&gt;\u2009$300, introduction of preventative routine TCV immunization with a catch-up campaign was the preferred strategy. Routine vaccination with a catch-up campaign was cost-effective for WTP values above $890 per DALY averted if no outbreak occurs and\u2009&gt;\u2009$140 per DALY averted if implemented after the outbreak has already occurred.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Countries for which the spread of antimicrobial resistance is likely to lead to outbreaks of typhoid fever should consider TCV introduction. Reactive vaccination can be a cost-effective strategy, but only if delays in vaccine deployment are minimal; otherwise, introduction of preventive routine immunization with a catch-up campaign is the preferred strategy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08105-2","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T09:04:45Z","timestamp":1678266285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6952-0440","authenticated-orcid":false,"given":"Maile T.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Antillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"Bilcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naor","family":"Bar-Zeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumbani","family":"Limani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Debellut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Pecenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Neuzil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melita A.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deus","family":"Thindwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. David","family":"Paltiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Yaesoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia E.","family":"Pitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"8105_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005376","author":"M Antillon","year":"2017","unstructured":"Antillon M, Warren J, Crawford F, Weinberger D, Kurum E, Pitzer V. The burden of typhoid fever in low- and middle-income countries: a meta-regression approach. PLoS Negl Trop Dis. 2017. https:\/\/doi.org\/10.1371\/journal.pntd.0005376.","journal-title":"PLoS Negl Trop Dis."},{"issue":"10159","key":"8105_CR2","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","author":"GBD 2017 Risk Factor Collaborators","year":"2018","unstructured":"GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). 2018;392(10159):1923\u201394. https:\/\/doi.org\/10.1016\/S0140-6736(18)32225-6.","journal-title":"Lancet (London, England)."},{"key":"8105_CR3","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) Results. Seattle2017. http:\/\/ghdx.healthdata.org\/gbd-results-tool."},{"issue":"1","key":"8105_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1128\/jcm.02026-14","volume":"53","author":"RS Hendriksen","year":"2015","unstructured":"Hendriksen RS, Leekitcharoenphon P, Lukjancenko O, Lukwesa-Musyani C, Tambatamba B, Mwaba J, et al. Genomic signature of multidrug-resistant salmonella enterica serovar typhi isolates related to a massive outbreak in Zambia between 2010 and 2012. J Clin Microbiol. 2015;53(1):262\u201372. https:\/\/doi.org\/10.1128\/jcm.02026-14.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"8105_CR5","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4269\/ajtmh.13-0497","volume":"90","author":"M Imanishi","year":"2014","unstructured":"Imanishi M, Kweza PF, Slayton RB, Urayai T, Ziro O, Mushayi W, et al. Household water treatment uptake during a public health response to a large typhoid fever outbreak in Harare, Zimbabwe. Am J Trop Med Hyg. 2014;90(5):945\u201354. https:\/\/doi.org\/10.4269\/ajtmh.13-0497.","journal-title":"Am J Trop Med Hyg."},{"issue":"8","key":"8105_CR6","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/cid\/cis025","volume":"54","author":"KP Neil","year":"2012","unstructured":"Neil KP, Sodha SV, Lukwago L, O-Tipo S, Mikoleit M, Simington SD, et al. A large outbreak of typhoid fever associated with a high rate of intestinal perforation in Kasese District, Uganda, 2008\u20132009. Clin Infect Dis. 2012;54(8):1091\u20139. https:\/\/doi.org\/10.1093\/cid\/cis025.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"8105_CR7","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1086\/529146","volume":"46","author":"MA Gordon","year":"2008","unstructured":"Gordon MA, Graham SM, Walsh AL, Wilson L, Phiri A, Molyneux E, et al. Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis. 2008;46(7):963\u20139. https:\/\/doi.org\/10.1086\/529146.","journal-title":"Clin Infect Dis"},{"key":"8105_CR8","doi-asserted-by":"publisher","first-page":"S251","DOI":"10.1093\/cid\/civ710","volume":"61","author":"VE Pitzer","year":"2015","unstructured":"Pitzer VE, Feasey NA, Msefula C, Mallewa J, Kennedy N, Dube Q, et al. Mathematical modeling to assess the drivers of the recent emergence of typhoid fever in Blantyre, Malawi. Clin Infect Dis. 2015;61:S251\u20138. https:\/\/doi.org\/10.1093\/cid\/civ710.","journal-title":"Clin Infect Dis"},{"key":"8105_CR9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035916","author":"P Patel","year":"2021","unstructured":"Patel P, Patel P, Liang Y, Meiring J, Misiri T, Mwakiseghile F, et al. Safety and efficacy of a typhoid conjugate vaccine in Malawian children. N Engl J Med. 2021. https:\/\/doi.org\/10.1056\/NEJMoa2035916.","journal-title":"N Engl J Med."},{"issue":"11","key":"8105_CR10","doi-asserted-by":"publisher","first-page":"E1561","DOI":"10.1016\/S2214-109X(21)00346-6","volume":"9","author":"M Shakya","year":"2021","unstructured":"Shakya M, Voysey M, Theiss-Nyland K, Colin-Jones R, Pant D, et al. Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial. Lancet Glob Health. 2021;9(11):E1561\u20138. https:\/\/doi.org\/10.1016\/S2214-109X(21)00346-6.","journal-title":"Lancet Glob Health"},{"issue":"10301","key":"8105_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0140-6736(21)01124-7","volume":"398","author":"F Qadri","year":"2021","unstructured":"Qadri F, Khanam F, Liu X, Theiss-Nyland K, Biswas PK, Bhuiyan AI. Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial. Lancet (London, England). 2021;398(10301):675\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(21)01124-7.","journal-title":"Lancet (London, England)."},{"key":"8105_CR12","first-page":"930","volume":"19","author":"ID Olaru","year":"2019","unstructured":"Olaru ID, Mtapuri-Zinyowera S, Feasey N, Ferrand RA, Kranzer K. Typhoid Vi-conjugate vaccine for outbreak control in Zimbabwe. Lancet (London, England). 2019;19:930.","journal-title":"Lancet (London, England)"},{"key":"8105_CR13","doi-asserted-by":"publisher","first-page":"C42","DOI":"10.1016\/S0022-5193(03)00031-6","volume":"33","author":"CH Watson","year":"2015","unstructured":"Watson CH, Edmunds WJ. A review of typhoid fever transmission dynamic models and economic evaluations of vaccination. Vaccine. 2015;33:C42\u201354. https:\/\/doi.org\/10.1016\/S0022-5193(03)00031-6.","journal-title":"Vaccine"},{"key":"8105_CR14","doi-asserted-by":"crossref","unstructured":"World Health Organization. Typhoid vaccines: WHO position paper, March 2018\u2014Recommendations. Vaccine. 2019;37(2).","DOI":"10.1016\/j.vaccine.2018.04.022"},{"key":"8105_CR15","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2014.1341","author":"AS Azman","year":"2015","unstructured":"Azman AS, Lessler J. Reactive vaccination in the presence of disease hotspots. Proc Biol Sci. 2015. https:\/\/doi.org\/10.1098\/rspb.2014.1341.","journal-title":"Proc Biol Sci"},{"issue":"1","key":"8105_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.inhe.2009.12.009","volume":"2","author":"KP Alberti","year":"2010","unstructured":"Alberti KP, King LA, Burny ME, Ilunga BK, Grais RF. Reactive vaccination as an effective tool for measles outbreak control in measles mortality reduction settings, Democratic Republic of Congo, 2005\u20132006. Int Health. 2010;2(1):65\u20138. https:\/\/doi.org\/10.1016\/j.inhe.2009.12.009.","journal-title":"Int Health"},{"issue":"7080","key":"8105_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nature04324","volume":"440","author":"MJ Tildesley","year":"2006","unstructured":"Tildesley MJ, Savill NJ, Shaw DJ, Deardon R, Brooks SP, Woolhouse MEJ, et al. Optimal reactive vaccination strategies for a foot-and-mouth outbreak in the UK. Nature. 2006;440(7080):83. https:\/\/doi.org\/10.1038\/nature04324.","journal-title":"Nature"},{"issue":"9","key":"8105_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001512","volume":"10","author":"I Ciglenecki","year":"2013","unstructured":"Ciglenecki I, Sakoba K, Luquero FJ, Heile M, Itama C, Mengel M, et al. Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea. PLoS Med. 2013;10(9): e1001512. https:\/\/doi.org\/10.1371\/journal.pmed.1001512.","journal-title":"PLoS Med."},{"issue":"11","key":"8105_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001901","volume":"6","author":"AS Azman","year":"2012","unstructured":"Azman AS, Luquero FJ, Rodrigues A, Palma PP, Grais RF, Banga CN, et al. Urban cholera transmission hotspots and their implications for reactive vaccination: evidence from Bissau City, Guinea Bissau. PLoS Negl Trop Dis. 2012;6(11): e1901. https:\/\/doi.org\/10.1371\/journal.pntd.0001901.","journal-title":"PLoS Negl Trop Dis."},{"issue":"8","key":"8105_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1098\/rsif.2007.1038","volume":"5","author":"RF Grais","year":"2008","unstructured":"Grais RF, Conlan AJK, Ferrari MJ, Djibo A, Menach AL, Bj\u00f8rnstad ON, et al. Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger. J R Soc Interface. 2008;5(8):67\u201374. https:\/\/doi.org\/10.1098\/rsif.2007.1038.","journal-title":"J R Soc Interface"},{"key":"8105_CR21","doi-asserted-by":"publisher","DOI":"10.5210\/ojphi.v9i1.7584","author":"RM Rosado","year":"2017","unstructured":"Rosado RM, Charles-Smith L, Daniel B. Control and cost-benefit analysis of fast spreading diseases: the case of ebola. Online J Public Health Inform. 2017. https:\/\/doi.org\/10.5210\/ojphi.v9i1.7584.","journal-title":"Online J Public Health Inform."},{"issue":"2","key":"8105_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/aje\/kwt236","volume":"179","author":"A Minetti","year":"2019","unstructured":"Minetti A, Hurtado N, Grais RF, Ferrari M. Reaching hard-to-reach individuals: nonselective versus targeted outbreak response vaccination for measles. Am J Epidemiol. 2019;179(2):245\u201351. https:\/\/doi.org\/10.1093\/aje\/kwt236.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"8105_CR23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S1473-3099(18)30804-1","volume":"19","author":"J Bilcke","year":"2019","unstructured":"Bilcke J, Antillon M, Pieters Z, Kuylen E, Abboud L, Neuzil KM, et al. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study. Lancet Infect Dis. 2019;19(7):728\u201339. https:\/\/doi.org\/10.1016\/S1473-3099(18)30804-1.","journal-title":"Lancet Infect Dis"},{"key":"8105_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix598","author":"N Lo","year":"2018","unstructured":"Lo N, Gupta R, Stanaway J, Garrett D, Bogoch I, Luby S, et al. Comparison of strategies and incidence thresholds for vi conjugate vaccines against typhoid fever: a cost-effectiveness modeling study. J Infect Dis. 2018. https:\/\/doi.org\/10.1093\/infdis\/jix598.","journal-title":"J Infect Dis"},{"issue":"4","key":"8105_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003748","volume":"9","author":"N Feasey","year":"2015","unstructured":"Feasey N, Gaskell K, Wong V, Msefula C, Selemani G, Kumwenda S, et al. Rapid emergence of multidrug resistant, H58-lineage Salmonella Typhi in Blantyre, Malawi. PLOS Negl Trop Dis. 2015;9(4): e0003748. https:\/\/doi.org\/10.1371\/journal.pntd.0003748.","journal-title":"PLOS Negl Trop Dis."},{"issue":"26","key":"8105_CR26","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1002\/sim.9159","volume":"40","author":"MT Phillips","year":"2021","unstructured":"Phillips MT, Meiring JE, Voysey M, Warren JL, Baker S, Basnyat B, et al. A Bayesian approach for estimating typhoid fever incidence from large-scale facility-based passive surveillance data. Stat Med. 2021;40(26):5853\u201370. https:\/\/doi.org\/10.1002\/sim.9159.","journal-title":"Stat Med"},{"key":"8105_CR27","unstructured":"United Nations Department of Economic and Social Affairs. World Population Prospects, the 2012 Revision [Report]. 2013 [updated 2013]. https:\/\/www.un.org\/en\/development\/desa\/publications\/world-population-prospects-the-2012-revision.html."},{"issue":"283","key":"8105_CR28","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1056\/NEJM197009242831306","volume":"1970","author":"RB Hornick","year":"1970","unstructured":"Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT, Snyder MJ. Typhoid fever: pathogenesis and immunologic control (part 1). N Engl J Med. 1970;1970(283):686\u201391. https:\/\/doi.org\/10.1056\/NEJM197009242831306.","journal-title":"N Engl J Med"},{"issue":"3","key":"8105_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2105\/AJPH.33.3.221","volume":"33","author":"WR Ames","year":"1943","unstructured":"Ames WR, Robins M. Age and sex as factors in the development of the typhoid carrier state, and a method for estimating carrier prevalence. Am J Public Health Nations Health. 1943;33(3):221\u201330.","journal-title":"Am J Public Health Nations Health"},{"issue":"5","key":"8105_CR30","first-page":"346","volume":"82","author":"JA Crump","year":"2004","unstructured":"Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. 2004;82(5):346\u201353.","journal-title":"Bull World Health Organ"},{"issue":"27","key":"8105_CR31","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1016\/j.vaccine.2017.05.001","volume":"35","author":"M Antillon","year":"2017","unstructured":"Antillon M, Bilcke J, Paltiel AD, Pitzer VE. Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings. Vaccine. 2017;35(27):3506\u201314. https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.001.","journal-title":"Vaccine"},{"key":"8105_CR32","doi-asserted-by":"publisher","unstructured":"Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. 2013. https:\/\/doi.org\/10.1136\/bmj.f1049.","DOI":"10.1136\/bmj.f1049"},{"key":"8105_CR33","unstructured":"World Health Organization. Making choices in health: WHO guide to cost-effectiveness analysis. WHO. 2003. entity\/choice\/book\/en\/index.html."},{"key":"8105_CR34","unstructured":"World Health Organization. WHO guide for standardization of economic evaluations of immunization programmes. Geneva : World Health Organization, 2008 2008. Report No."},{"key":"8105_CR35","unstructured":"NICE International. Bill and Melinda Gates Foundation Methods for Economic Evaluation Project (MEEP): Final Report. 2014."},{"issue":"9859","key":"8105_CR36","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/s0140-6736(12)61689-4","volume":"380","author":"CJ Murray","year":"2012","unstructured":"Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England). 2012;380(9859):2197\u2013223. https:\/\/doi.org\/10.1016\/s0140-6736(12)61689-4.","journal-title":"Lancet (London, England)."},{"issue":"5","key":"8105_CR37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3201\/eid0905.020428","volume":"9","author":"JA Crump","year":"2003","unstructured":"Crump JA, Youssef FG, Luby SP, Wasfy MO, Rangel JM, Taalat M, et al. Estimating the incidence of typhoid fever and other febrile illnesses in developing countries. Emerg Infect Dis. 2003;9(5):539\u201344. https:\/\/doi.org\/10.3201\/eid0905.020428.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"8105_CR38","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/cid\/ciy190","volume":"67","author":"Z Pieters","year":"2018","unstructured":"Pieters Z, Saad NJ, Antill\u00f3n M, Pitzer VE, Bilcke J. Case fatality rate of enteric fever in endemic countries: a systematic review and meta-analysis. Clin Infect Dis. 2018;67(4):628\u201338. https:\/\/doi.org\/10.1093\/cid\/ciy190.","journal-title":"Clin Infect Dis"},{"key":"8105_CR39","unstructured":"World Bank. Life expectancy at birth, total (years) 2021. 2019 Revision: https:\/\/data.worldbank.org\/indicator\/SP.DYN.LE00.IN."},{"key":"8105_CR40","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1214074\/v1","author":"F Limani","year":"2021","unstructured":"Limani F, Smith C, Wachepa R, Chafuwa H, Meiring J, Noah P, et al. Estimating the economic burden of typhoid in children and adults in Blantyre, Malawi: a costing cohort study. Res Square. 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-1214074\/v1.","journal-title":"Res Square"},{"issue":"6","key":"8105_CR41","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jinf.2020.10.030","volume":"81","author":"CS Marchello","year":"2020","unstructured":"Marchello CS, Birkhold M, Crump JA. Complications and mortality of typhoid fever: a global systematic review and meta-analysis. J Infect. 2020;81(6):902\u201310. https:\/\/doi.org\/10.1016\/j.jinf.2020.10.030.","journal-title":"J Infect"},{"key":"8105_CR42","doi-asserted-by":"publisher","unstructured":"Darton TC, Meiring JE, Tonks S, Khan MA, Khanam F, Shakya M, et al. The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys. 2017. doi: https:\/\/doi.org\/10.1136\/bmjopen-2017-016283.","DOI":"10.1136\/bmjopen-2017-016283"},{"key":"8105_CR43","volume-title":"Global hospitalization rate of typhoid fever: a meta-regression","author":"L Abboud","year":"2017","unstructured":"Abboud L. Global hospitalization rate of typhoid fever: a meta-regression. Antwerp: University of Antwerp; 2017."},{"issue":"9859","key":"8105_CR44","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/s0140-6736(12)61680-8","volume":"380","author":"JA Salomon","year":"2012","unstructured":"Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (London, England). 2012;380(9859):2129\u201343. https:\/\/doi.org\/10.1016\/s0140-6736(12)61680-8.","journal-title":"Lancet (London, England)."},{"issue":"6","key":"8105_CR45","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/0272989X12465123","volume":"33","author":"MO Strong","year":"2012","unstructured":"Strong MO, Jeremy E. An efficient method for computing single-parameter partial expected value of perfect information. Med Decis Making. 2012;33(6):755\u201366. https:\/\/doi.org\/10.1177\/0272989X12465123.","journal-title":"Med Decis Making"},{"issue":"1","key":"8105_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12962-018-0095-x","volume":"16","author":"K Stenberg","year":"2018","unstructured":"Stenberg K, Lauer JA, Gkountouras G, Fitzpatrick C, Stanciole A. Econometric estimation of WHO-CHOICE country-specific costs for inpatient and outpatient health service delivery. Cost Effect Resour Alloc. 2018;16(1):1\u201315. https:\/\/doi.org\/10.1186\/s12962-018-0095-x.","journal-title":"Cost Effect Resour Alloc"},{"key":"8105_CR47","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017."},{"issue":"6","key":"8105_CR48","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.4269\/ajtmh.19-0624","volume":"102","author":"GD Appiah","year":"2022","unstructured":"Appiah GD, Chung A, Bentsi-Enchill AD, Kim S, Crump JA, Mogasale V, et al. Typhoid outbreaks, 1989\u20132018: implications for prevention and control. Am J Trop Med Hyg. 2022;102(6):1296\u2013305. https:\/\/doi.org\/10.4269\/ajtmh.19-0624.","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"8105_CR49","doi-asserted-by":"publisher","first-page":"E1688","DOI":"10.1016\/S2214-109X(21)00370-3","volume":"9","author":"JE Meiring","year":"2022","unstructured":"Meiring JE, Shakya M, Khanam F, Voysey M, Phillips MT, Tonks S, et al. Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study. Lancet Glob Health. 2022;9(12):E1688\u201396. https:\/\/doi.org\/10.1016\/S2214-109X(21)00370-3.","journal-title":"Lancet Glob Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08105-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T09:06:14Z","timestamp":1678266374000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08105-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8105"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08105-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]},"assertion":[{"value":"24 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"VEP is a member of the World Health Organization's (WHO) Immunization and Vaccine-related Implementation Research Advisory Committee and has received reimbursements from Merck and Pfizer for travel to Scientific Input Engagements unrelated to the topic of this manuscript. The views expressed in this manuscript are those of the authors and do not necessarily reflect the views of the WHO. All other authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}